|
ZCCHC8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.01210000000596E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.06560000000078E-05 |
| Normal-vs-Stage2 |
1.120240E-03 |
| Normal-vs-Stage3 |
3.31840000034056E-07 |
| Normal-vs-Stage4 |
1.610640E-04 |
| Stage1-vs-Stage2 |
6.841600E-01 |
| Stage1-vs-Stage3 |
3.048100E-02 |
| Stage1-vs-Stage4 |
3.606200E-01 |
| Stage2-vs-Stage3 |
2.873200E-01 |
| Stage2-vs-Stage4 |
7.120000E-01 |
| Stage3-vs-Stage4 |
5.196200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.64399999952525E-07 |
| Normal-vs-AfricanAmerican |
4.441900E-04 |
| Normal-vs-Asian |
1.893580E-02 |
| Caucasian-vs-AfricanAmerican |
6.748400E-01 |
| Caucasian-vs-Asian |
8.326100E-02 |
| AfricanAmerican-vs-Asian |
9.440200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.562900E-04 |
| Normal-vs-Female |
1.81510000030194E-07 |
| Male-vs-Female |
2.064800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.431930E-04 |
| Normal-vs-Age(41-60Yrs) |
1.6990899999958E-05 |
| Normal-vs-Age(61-80Yrs) |
9.20530000003694E-07 |
| Normal-vs-Age(81-100Yrs) |
1.222560E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.157200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.720200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.990000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.961210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.540580E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.007600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.297300E-03 |
| Classical-VS-Follicular |
1.861020E-01 |
| Classical-VS-Other |
9.824000E-01 |
| Classical-VS-Normal |
1.998120E-04 |
| Tall-VS-Follicular |
1.157580E-01 |
| Tall-VS-Other |
1.602800E-01 |
| Tall-VS-Normal |
7.53020000021642E-07 |
| Follicular-VS-Other |
6.693400E-01 |
| Follicular-VS-Normal |
1.404050E-04 |
| Other-VS-Normal |
1.402950E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.89250000004471E-07 |
| Normal-vs-N1 |
1.817820E-04 |
| N0-vs-N1 |
8.337200E-01 |
|
|
